A high index of suspicion for sigmoid volvulus is needed in young women with abdominal symptoms as the overlap of gastrointestinal and gynecological symptoms can easily lead to misdiagnosis.
Another case report contributing to the growing body of literature on gastrointestinal involvement in systemic lupus erythematosus, and underscoring the importance of early recognition and targeted treatment.
The treatment strategy for liver metastases is predominantly determined by the primary cancer site, which made this patient with metastases from breast and colorectal cancer quite challenging to manage.
Combination therapies involving novel drugs hold promise for improving chronic hepatitis B outcomes, particularly in achieving a functional cure. What are these novel drugs and how might they be combined to improve efficacy?
The global burden of ALD is growing and compounded by frequent late-stage diagnosis and undertreatment. Get the latest insights into patient risk and identification, treatment and management, and the arrival of MetALD.
Watch it live: 19 November 2025, 18:00-19:30 (CET)
Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.
A high index of suspicion for sigmoid volvulus is needed in young women with abdominal symptoms as the overlap of gastrointestinal and gynecological symptoms can easily lead to misdiagnosis.
Another case report contributing to the growing body of literature on gastrointestinal involvement in systemic lupus erythematosus, and underscoring the importance of early recognition and targeted treatment.
The treatment strategy for liver metastases is predominantly determined by the primary cancer site, which made this patient with metastases from breast and colorectal cancer quite challenging to manage.
In 2005 the US FDA approved the first GLP-1 medicine for type 2 diabetes, marking the start of a remarkable journey that goes beyond the stimulation of insulin secretion.
Prof. Daniel Drucker gives us a fascinating insight into the early work on GLP-1 and discusses how these medicines are impacting the lives of people with diabetes and obesity. He covers what's known about how they work, treatment duration, side effects, and the role of bariatric surgery, plus what's in the pipeline in terms of drug development and the indications that GLP-1 medicines may be used to treat in the future.
Obesity is now firmly recognized as a complex, chronic, relapsing, and progressive disease, affecting over 650 million adults worldwide. It is a major driver of type 2 diabetes (T2D), atherosclerotic cardiovascular disease (ASCVD), heart failure …
The management of acute appendicitis has undergone a substantial transformation in recent years, transitioning from mandatory surgical intervention to more individualized treatment strategies. This systematic review and meta-analysis aim to …
Tirzepatide is the first dual long-acting glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor agonist indicated for the treatment of type 2 diabetes in adults, for reducing excess body weight and maintaining …
Obesity is a major contributor to cardiorenal metabolic disease, but its impact extends throughout the body. Understand how obesity can affect other organ systems and impact treatment, and whether weight-loss measures improve outcomes.
Update your awareness of the phenotypes and clinical presentations of late-onset genetic cholestasis. Learn how to integrate consensus recommendations and diagnostic tools for accurate diagnosis, and discover treatment advances.
Experts from established amyloidosis centers offer you specialized guidance to support your mission to set up a local center. Roundtable insights allow you to network with other HCPs in your locality to discuss region-specific challenges in establishing amyloidosis centers.
Severe pain is the most common symptom of chronic pancreatitis. In this live webinar, experts shared the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discussed pertinent cases and provided practical suggestions for use within clinical practice.
Colorectal cancer (CRC) is the third most common malignant tumor globally exhibiting a rising incidence rate-particularly among younger populations under 50, where rates increased annually in recent years [ 1 ]. According to the World Health …
Approximately 5% of all colorectal cancers have a strong genetic component and are classified as hereditary colorectal cancer (HCRC). Some of the unique features commonly seen in HCRC cases include early age of onset, synchronous/metachronous …
Obesity is now firmly recognized as a complex, chronic, relapsing, and progressive disease, affecting over 650 million adults worldwide. It is a major driver of type 2 diabetes (T2D), atherosclerotic cardiovascular disease (ASCVD), heart failure …
A high index of suspicion for sigmoid volvulus is needed in young women with abdominal symptoms as the overlap of gastrointestinal and gynecological symptoms can easily lead to misdiagnosis.
